We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Methylation Enzyme Modifies Gene Behavior

By Biotechdaily staff writers
Posted on 24 May 2002
An enzyme has been found that attaches methyl groups to histone proteins and represses the activity of certain genes. More...
The research was reported in the April 15, 2002, issue of Genes and Development.

Histone proteins are packaged together with DNA in the chromosomes. If methylation of these proteins is blocked, genes that normally are repressed may become activated. Such activated genes may transform normal cells into cancerous ones.

"In this study we showed that when this enzyme is active at a particular gene, it places a molecular marker on the gene, says Dr. Frank J. Rauscher III, a professor at The Wistar Institute (Philadelphia, PA, USA). "This molecular marker is crucial in silencing sets of genes.” Loss of this molecular marker from a particular set of genes in a normally nonaggressive breast cancer can cause it to become very aggressive and metastatic.

"Now that we have found a new enzyme that is required for the silencing of certain genes,” states Dr. Rauscher, "we believe it will be possible to create specific drugs that can either repress or activate gene expression through the targeting of this enzyme. This could lead to therapies for cancer and, specifically, for controlling the metastatic spread of cancer.”




Related Links:
The Wistar Institute

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.